Cargando…
1345. Randomized Control Trial to Evaluate the Clinical and Cytokine Response Profile to Oral Thalidomide in Leprosy Patients with Erythema Nodosum Leprosum
BACKGROUND: Leprosy is a chronic granulomatous disease caused by Mycobacterium leprae. Erythema Nodosum Leprosum is an acute inflammatory Type III hypersensitivity response during the chronic course of the disease process. This immune response manifests clinically as painful red nodules and systemic...
Autores principales: | Chopra, Ajay, Mitra, Debdeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809130/ http://dx.doi.org/10.1093/ofid/ofz360.1209 |
Ejemplares similares
-
812. Case–Control Trial to Evaluate the Cytokine Response to the Use of Capsule Thalidomide in Erythema Nodosum Leprosum in Leprosy Patients
por: Chopra, Ajay, et al.
Publicado: (2018) -
Thalidomide and steroid in the management of erythema nodosum leprosum
por: Mishra, S. R. P. K., et al.
Publicado: (2022) -
A Case of Lepromatous Leprosy With Erythema Nodosum Leprosum
por: Park, Lily, et al.
Publicado: (2023) -
Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019) -
Etanercept in erythema nodosum leprosum
por: Santos, Julia Rocha Silva, et al.
Publicado: (2017)